alprazolam has been researched along with Cognition Disorders in 7 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alprazolam was as effective as low dose haloperidol in this population." | 2.69 | Alprazolam as an alternative to low-dose haloperidol in older, cognitively impaired nursing facility patients. ( Benfield, WR; Christensen, DB, 1998) |
| "Transgenic R6/2 mice carrying the Huntington's disease (HD) mutation show disrupted circadian rhythms that worsen as the disease progresses." | 1.34 | Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease. ( Chesham, JE; Dyball, R; Hastings, MH; Inyushkin, AN; Maywood, ES; Morton, AJ; Pallier, PN; Zheng, Z, 2007) |
| "Imidazenil is a highly potent partial allosteric modulator of gamma-aminobutyric acid action at a great variety of gamma-aminobutyric acid(A) receptors, whereas alprazolam is a full allosteric modulator at these receptors." | 1.29 | Imidazenil, a new anxiolytic and anticonvulsant drug, attenuates a benzodiazepine-induced cognition deficit in monkeys. ( Auta, J; Costa, E; Guidotti, A; Thompson, DM, 1995) |
| " The results have implications for evaluating the safety of the long-term use of BZ medications." | 1.27 | Chronic use of benzodiazepines and psychomotor and cognitive test performance. ( Geller, AM; Lucki, I; Rickels, K, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pallier, PN | 2 |
| Morton, AJ | 2 |
| Vandesquille, M | 1 |
| Carrié, I | 1 |
| Louis, C | 1 |
| Beracochea, D | 1 |
| Lestage, P | 1 |
| Snyder, PJ | 1 |
| Werth, J | 1 |
| Giordani, B | 1 |
| Caveney, AF | 1 |
| Feltner, D | 1 |
| Maruff, P | 1 |
| Maywood, ES | 1 |
| Zheng, Z | 1 |
| Chesham, JE | 1 |
| Inyushkin, AN | 1 |
| Dyball, R | 1 |
| Hastings, MH | 1 |
| Thompson, DM | 1 |
| Auta, J | 1 |
| Guidotti, A | 1 |
| Costa, E | 1 |
| Christensen, DB | 1 |
| Benfield, WR | 1 |
| Lucki, I | 1 |
| Rickels, K | 1 |
| Geller, AM | 1 |
2 trials available for alprazolam and Cognition Disorders
| Article | Year |
|---|---|
A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Association Learning; Attention; Cognition Disorders; Double | 2005 |
Alprazolam as an alternative to low-dose haloperidol in older, cognitively impaired nursing facility patients.
Topics: Aged; Aged, 80 and over; Alprazolam; Anti-Anxiety Agents; Antipsychotic Agents; Behavioral Symptoms; | 1998 |
5 other studies available for alprazolam and Cognition Disorders
| Article | Year |
|---|---|
Management of sleep/wake cycles improves cognitive function in a transgenic mouse model of Huntington's disease.
Topics: Affect; Alprazolam; Animals; Benzhydryl Compounds; Body Weight; Central Nervous System Stimulants; C | 2009 |
Effects of positive modulators of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors in a benzodiazepine-induced deficit of spatial discrimination in mice.
Topics: Alprazolam; Amnesia; Animals; Behavior, Animal; Benzothiadiazines; Cognition Disorders; Discriminati | 2012 |
Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease.
Topics: Age Factors; Alprazolam; Animals; Cell Cycle Proteins; Chloral Hydrate; Choice Behavior; Circadian R | 2007 |
Imidazenil, a new anxiolytic and anticonvulsant drug, attenuates a benzodiazepine-induced cognition deficit in monkeys.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Cognition Disorders; Ery | 1995 |
Chronic use of benzodiazepines and psychomotor and cognitive test performance.
Topics: Adult; Affect; Aged; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Clorazepate Dipotassium; Cogn | 1986 |